Sort
51,570 grants matching “autoimmune disease”
ER-aminopeptidases: Conformational regulation and antigen presentation function
$502,500Lawrence J Stern · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · AI
Rip Proteins in Innate Immune Signaling
$502,500Michelle Alice Kelliher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · AI
Rip Proteins in Innate Immune Signaling
$502,500Michelle Alice Kelliher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · AI
ER-aminopeptidases: Conformational regulation and antigen presentation function
$502,500Lawrence J Stern · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · AI
dnTGF Beta RII Mice and PBC
$502,486Merrill E Gershwin · University Of California At Davis · R01 · FY2017 · DK
Rheumatic Diseases Core Center
$502,471University Of Alabama At Birmingham · P30 · FY2001 · AR
NEDD4 IN T HELPER CELL DEVELOPMENT AND AUTOIMMUNITY
$502,462Jian Zhang · University Of Iowa · R01 · FY2018 · AI
Development and conduct of allogeneic stem cell transplant and autologous stem cell gene therapy for inherited immune deficiencies
$502,432Elizabeth Kang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Development and Clinical Application of Gene and Cell therapies for Patients with Immune Deficiencies
$502,432Suk De Ravin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Role of Novel T Cell Costimulatory Pathways in Allograft Rejection and Tolerance
$502,382Mohamed H Sayegh · University Of Pennsylvania · P01 · FY2008 · AI
dnTGF Beta RII Mice and PBC
$502,329Merrill E Gershwin · University Of California At Davis · R01 · FY2015 · DK
Developing UPR inhibitory KIRAs into oral antidiabetic beta cell-sparing drugs
$502,298Feroz R Papa · University Of California, San Francisco · R01 · FY2021 · DK
Developing UPR inhibitory KIRAs into oral antidiabetic beta cell-sparing drugs
$502,298Feroz R Papa · University Of California, San Francisco · R01 · FY2022 · DK
Developing UPR inhibitory KIRAs into oral antidiabetic beta cell-sparing drugs
$502,298Feroz R Papa · University Of California, San Francisco · R01 · FY2018 · DK
Developing UPR inhibitory KIRAs into oral antidiabetic beta cell-sparing drugs
$502,298Feroz R Papa · University Of California, San Francisco · R01 · FY2020 · DK
Developing UPR inhibitory KIRAs into oral antidiabetic beta cell-sparing drugs
$502,298Feroz R Papa · University Of California, San Francisco · R01 · FY2019 · DK
IN VIVO IMAGE ANALYSIS OF AUTOREACTIVE T CELLS
$502,250University Of Alabama At Birmingham · R01 · FY2000 · AI
IN VIVO IMAGE ANALYSIS OF AUTOREACTIVE T CELLS
$502,250University Of Alabama At Birmingham · R01 · FY2003 · AI
IN VIVO IMAGE ANALYSIS OF AUTOREACTIVE T CELLS
$502,250University Of Alabama At Birmingham · R01 · FY2001 · AI
INPP5E Signaling and Treatment in Rheumatoid Arthritis
$502,204Shuying Yang · University Of Pennsylvania · R01 · FY2025 · AR
iSCREEN: An Integrative Data and Annotation Platform of Gene Regulation for Immune-mediated Disease Research
$502,202Zhiping Weng · Univ Of Massachusetts Med Sch Worcester · U01 · FY2023 · AI
iSCREEN: An Integrative Data and Annotation Platform of Gene Regulation for Immune-mediated Disease Research
$502,202Zhiping Weng · Univ Of Massachusetts Med Sch Worcester · U01 · FY2024 · AI
Molecular mechanisms underlying NHP pancreatic beta cell failure, and recovery
$502,127David Marshall Harlan · Univ Of Massachusetts Med Sch Worcester · R24 · FY2011 · DK
Association of Positional Candidate Gene Variants with SLE
$502,099Betty P. Tsao · University Of California Los Angeles · R01 · FY2011 · AR
dnTGF Beta RII Mice and PBC
$502,072Merrill E Gershwin · University Of California At Davis · R01 · FY2016 · DK